Publications by authors named "K Kjoller"

Claim this Profile
O
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS).
Jonathan I Silverberg, Lawrence F Eichenfield, Andrew Blauvelt, Alan D Irvine, Emma Guttman-Yassky

Br J Dermatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Sugar Molecular Weight on the Miscibility and Stability of Lyophilized and Spray-Dried Protein Formulations.
Hanh Thuy Nguyen, Mennatallah A Mohamed, Jing Ling, Yong Du, Kevin Kjoller

Mol Pharm· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Widefield Super-Resolution Infrared Spectroscopy and Imaging of Autofluorescent Biological Materials and Photosynthetic Microorganisms Using Fluorescence Detected Photothermal Infrared (FL-PTIR).
Craig B Prater, Kevin J Kjoller, Andrew P D Stuart, David A Grigg, Rinuk 'Limurn

Appl Spectrosc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS).
Richard B Warren, Lars E French, Andrew Blauvelt, Richard G Langley, Alexander Egeberg

J Am Acad Dermatol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacology of orismilast, a potent and selective PDE4 inhibitor.
Jonathan I Silverberg, Lars E French, Richard B Warren, Bruce Strober, Kim Kjøller

J Eur Acad Dermatol Venereol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis